Search Result for "breast cancer"
Clinical Trial

MONITOR-Breast: Monitoring cell-free tumor DNA as a marker of recurrence in Breast Cancer

This is a prospective, observational study designed to evaluate the clinical validity of Myriad Genetics’ MRD test in patients diagnosed with breast cancer. It is expected that enrollment will be split between the different breast cancer subtypes defined by immunohistochemistry (HR+/HER2-, HER2+ (HR+ and HR-), TNBC) and according to BINV-A of National Comprehensive Cancer Network guidelines with ER+ status used here as >10% of nuclei staining.

Story

Breast cancer survivor clinical trial offers recovery and hope

Lindsay Fry is a breast cancer survivor who was first diagnosed in 2019. Her treatment regimen of surgery, radiation and chemotherapy began in fall 2019. Shortly after completing her treatment, Fry became the first participant in a new clinical trial at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) that aims to help breast cancer survivors regain their energy and remain cancer free.

Story

How genetic testing could determine your risk of getting breast cancer

Natalie Poullard, MA, MS, CGC, a certified genetic counselor at Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, provides a brief understanding of genetic testing benefits, the types of tests available and what you can expect during an appointment.  Watch here

Cancer Treatment
Stereotactic Body Radiotherapy (SBRT)

At Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, our radiation oncologists combine advanced technologies with exceptional cancer expertise.